As demonstrated, an aptamer-modified exosomes carrying SIRT6-targeted siRNA significantly inhibited the growth and metastasis of prostate cancer both in vitro and in vivo through silencing SIRT6 [413]. Here, SIRT6 is linked to prostate carcinoma.